Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Guanglei Yu"'
Autor:
Brittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, Alexander Egeberg, Yves Dutronc, Frederick Durand, Evangeline Pierce, Guanglei Yu, Yun-Fei Chen, Arash Mostaghimi
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 7, Pp 1959-1968 (2024)
Abstract Introduction Alopecia areata (AA) is an autoimmune disease associated with high rates of emotional and psychosocial distress. The analysis reported here describes the evolution of measures assessing health-related quality of life (HRQoL) and
Externí odkaz:
https://doaj.org/article/77e79c209cff4bac862ba5ee5471c742
Autor:
Brittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, Alexander Egeberg, Yves Dutronc, Frederick Durand, Evangeline Pierce, Guanglei Yu, Yun-Fei Chen, Arash Mostaghimi
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 11, Pp 3193-3193 (2024)
Externí odkaz:
https://doaj.org/article/9f5959c675a2434ebb416516ba307bc5
Autor:
Alexander Egeberg, Louise Linsell, Erin Johansson, Frederick Durand, Guanglei Yu, Sergio Vañó-Galván
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 12, Pp 2951-2991 (2023)
Abstract Treatments for alopecia areata (AA) have traditionally been prescribed off-label, and there has been no universal agreement on how to best manage the condition. Baricitinib is the first oral selective Janus kinase (JAK) inhibitor approved fo
Externí odkaz:
https://doaj.org/article/8025ebc2714946fdb59e843ab15f1ea8
Publikováno v:
BMC Bioinformatics, Vol 24, Iss 1, Pp 1-15 (2023)
Abstract Background The identification of disease-related genes is of great significance for the diagnosis and treatment of human disease. Most studies have focused on developing efficient and accurate computational methods to predict disease-causing
Externí odkaz:
https://doaj.org/article/c66c264b015441c28c315f25e6775223
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background The greatly accelerated development of information technology has conveniently provided adoption for risk stratification, which means more beneficial for both patients and clinicians. Risk stratification offers accurate individual
Externí odkaz:
https://doaj.org/article/5c54b379f3e64cf5a020609a2a9471de
Publikováno v:
Chinese Journal of Mechanical Engineering, Vol 34, Iss 1, Pp 1-17 (2021)
Abstract A novel two-dimensional ultrasonic surface burnishing process (2D-USBP) is proposed. 7075-T6 aluminum samples are processed by a custom-designed 2D-USBP setup. Parameter optimization of 2D-USBP is conducted to determine the best processing s
Externí odkaz:
https://doaj.org/article/6167967a97eb46ac9e5e8390148c6c7e
Autor:
Ohsang Kwon, Maryanne M. Senna, Rodney Sinclair, Taisuke Ito, Yves Dutronc, Chen-Yen Lin, Guanglei Yu, Chiara Chiasserini, Jill McCollam, Wen-Shuo Wu, Brett King
Publikováno v:
American Journal of Clinical Dermatology. 24:443-451
Publikováno v:
Journal of Biopharmaceutical Statistics. 32:4-20
In pediatric or orphan diseases, there are many instances where it is unfeasible to conduct randomized and controlled clinical trials. This is due in part to the difficulty of enrolling a sufficient number of patients over a reasonable time period to
Publikováno v:
Journal of biopharmaceutical statistics.
As the regulatory environment becomes progressively receptive toward utilizing real-world evidence, a spectrum of real-world data incorporation techniques in trial conduct and analysis has seen increasing interest and adoption in different stages of
Autor:
Brett, King, Manabu, Ohyama, Ohsang, Kwon, Abraham, Zlotogorski, Justin, Ko, Natasha A, Mesinkovska, Maria, Hordinsky, Yves, Dutronc, Wen-Shuo, Wu, Jill, McCollam, Chiara, Chiasserini, Guanglei, Yu, Sarah, Stanley, Katrin, Holzwarth, Amy M, DeLozier, Rodney, Sinclair, Matthew, Zirwas
Publikováno v:
The New England journal of medicine. 386(18)
Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited. Baricitinib, an oral, selective, reversible inhibitor of Janus kinases 1 and 2, may interrupt cytokin